Haohai Bio-Tech Subsidiary Secures Medical Device Registration for Multifocal Aspheric Intraocular Lens

Stock News
04/07

Shanghai Haohai Biological Technology Co., Ltd. (688366.SH) has announced that its wholly-owned subsidiary, Henan Universe Intraocular Lens Research Co., Ltd., recently obtained a Medical Device Registration Certificate from the National Medical Products Administration for its multifocal aspheric intraocular lens product. This product is the world's first approved multifocal intraocular lens based on Fourier harmonic penta-focal diffractive patented technology. It enables more efficient light energy distribution, improves light utilization efficiency, enhances intermediate vision compared to traditional trifocal lenses, and provides a smoother, more continuous visual experience across far, intermediate, and near distances.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10